Yufeng Hu
- Cancer Research top 10%
- Biochemistry top 10%
-
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Peroxisome Proliferator-Activated Receptors 3
- Glycosylation and Glycoproteins Research 2
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease 4
-
- Liver Disease Diagnosis and Treatment 7
-
- Adipose Tissue and Metabolism 3
-
- interferon and immune responses 2
- Journals
- Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)
- Partner nations
- ChinaBelgiumUnited States
In The Last Decade
Yufeng Hu
36 papers receiving 900 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 234
- Biochemistry 59
- Molecular Biology 541
- Cell Biology 121
- Hepatology 49
Countries citing papers authored by Yufeng Hu
This map shows the geographic impact of Yufeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufeng Hu more than expected).
Fields of papers citing papers by Yufeng Hu
This network shows the impact of papers produced by Yufeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufeng Hu. The network helps show where Yufeng Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yufeng Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 13 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 11 | |
| 7 | 2022 | 11 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 70 | |
| 10 | 2021 | 21 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 49 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 14 | |
| 16 | 2018 | 24 | |
| 17 | 2017 | 30 | |
| 18 | 2016 | 29 | |
| 19 | 2014 | 26 | |
| 20 | 2014 | 29 |
About Yufeng Hu
Yufeng Hu is a scholar working on Equine, Biochemistry and Cell Biology, having authored 36 papers that have together received 910 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Endoplasmic Reticulum Stress and Disease (4 papers), RNA modifications and cancer (4 papers), Ubiquitin and proteasome pathways (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Adipose Tissue and Metabolism (3 papers), interferon and immune responses (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (234 citations), Biochemistry (59 citations) and Molecular Biology (541 citations). Yufeng Hu has collaborated with scholars based in China, Belgium and United States. Frequent co-authors include Hudan Liu, Guoliang Qing, Hexiu Su, Daibiao Xiao, Ping Ren, Hongliang Li, Song Tian, Ming Yue, Hai‐Ning Du and Jue Jiang. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.